NCT02906059 2020-10-12Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal CancerNYU Langone HealthPhase 1 Completed7 enrolled